» Articles » PMID: 27556693

Association Mining of Mutated Cancer Genes in Different Clinical Stages Across 11 Cancer Types

Overview
Journal Oncotarget
Specialty Oncology
Date 2016 Aug 25
PMID 27556693
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Many studies have demonstrated that some genes (e.g. APC, BRAF, KRAS, PTEN, TP53) are frequently mutated in cancer, however, underlying mechanism that contributes to their high mutation frequency remains unclear. Here we used Apriori algorithm to find the frequent mutational gene sets (FMGSs) from 4,904 tumors across 11 cancer types as part of the TCGA Pan-Cancer effort and then mined the hidden association rules (ARs) within these FMGSs. Intriguingly, we found that well-known cancer driver genes such as BRAF, KRAS, PTEN, and TP53 were often co-occurred with other driver genes and FMGSs size peaked at an itemset size of 3~4 genes. Besides, the number and constitution of FMGS and ARs differed greatly among different cancers and stages. In addition, FMGS and ARs were rare in endocrine-related cancers such as breast carcinoma, ovarian cystadenocarcinoma, and thyroid carcinoma, but abundant in cancers contact directly with external environments such as skin melanoma and stomach adenocarcinoma. Furthermore, we observed more rules in stage IV than in other stages, indicating that distant metastasis needed more sophisticated gene regulatory network.

Citing Articles

Teneurins: Role in Cancer and Potential Role as Diagnostic Biomarkers and Targets for Therapy.

Peppino G, Ruiu R, Arigoni M, Riccardo F, Iacoviello A, Barutello G Int J Mol Sci. 2021; 22(5).

PMID: 33652578 PMC: 7956758. DOI: 10.3390/ijms22052321.


The Down-Regulation of lncRNA PCAT18 Promotes the Progression of Gastric Cancer via MiR-107/PTEN/PI3K/AKT Signaling Pathway.

Chen P, Zhao X, Wang H, Zheng M, Wang Q, Chang W Onco Targets Ther. 2019; 12:11017-11031.

PMID: 31853187 PMC: 6916702. DOI: 10.2147/OTT.S225235.


Population-based statistical inference for temporal sequence of somatic mutations in cancer genomes.

Rhee J, Kim T BMC Med Genomics. 2018; 11(Suppl 2):29.

PMID: 29697365 PMC: 5918460. DOI: 10.1186/s12920-018-0352-z.


ANGPTL1 attenuates colorectal cancer metastasis by up-regulating microRNA-138.

Chen H, Xiao Q, Hu Y, Chen L, Jiang K, Tang Y J Exp Clin Cancer Res. 2017; 36(1):78.

PMID: 28606130 PMC: 5467265. DOI: 10.1186/s13046-017-0548-7.

References
1.
Forbes S, Beare D, Gunasekaran P, Leung K, Bindal N, Boutselakis H . COSMIC: exploring the world's knowledge of somatic mutations in human cancer. Nucleic Acids Res. 2014; 43(Database issue):D805-11. PMC: 4383913. DOI: 10.1093/nar/gku1075. View

2.
Stratton M, Campbell P, Futreal P . The cancer genome. Nature. 2009; 458(7239):719-24. PMC: 2821689. DOI: 10.1038/nature07943. View

3.
Tomasetti C, Marchionni L, Nowak M, Parmigiani G, Vogelstein B . Only three driver gene mutations are required for the development of lung and colorectal cancers. Proc Natl Acad Sci U S A. 2014; 112(1):118-23. PMC: 4291633. DOI: 10.1073/pnas.1421839112. View

4.
Parker J, Mullins M, Cheang M, Leung S, Voduc D, Vickery T . Supervised risk predictor of breast cancer based on intrinsic subtypes. J Clin Oncol. 2009; 27(8):1160-7. PMC: 2667820. DOI: 10.1200/JCO.2008.18.1370. View

5.
Giannakis M, Hodis E, Mu X, Yamauchi M, Rosenbluh J, Cibulskis K . RNF43 is frequently mutated in colorectal and endometrial cancers. Nat Genet. 2014; 46(12):1264-6. PMC: 4283570. DOI: 10.1038/ng.3127. View